إعلان
إعلان
VTVT
vTv Therapeutics Inc. Class A Common Stock
41.44
USDبرعاية
-0.55
-1.32%
٠٨ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
41.44
0.00
0.00%
تقارير أرباح VTVT
النسبة الإيجابية المفاجئة
VTVT تفوق 21 من 34 آخر التقديرات.
62%
التقرير التالي
بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.07
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-0.93%
التغير الضمني من Q4 24 (Revenue/ EPS)
-100.00%
/+94.55%
vTv Therapeutics Inc. Class A Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, VTVT reported earnings of -1.08 USD per share (EPS) for Q3 25, missing the estimate of -0.99 USD, resulting in a -8.04% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.16% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -1.07 USD, with revenue projected to reach -- USD, implying an نقصان of -0.93% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were vTv Therapeutics Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, vTv Therapeutics Inc. Class A Common Stock reported EPS of -$1.08, missing estimates by -8.04%, and revenue of $0.00, 0% as expectations.
How did the market react to vTv Therapeutics Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 2.16%, changed from $25.47 before the earnings release to $26.02 the day after.
When is vTv Therapeutics Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
What are the forecasts for vTv Therapeutics Inc. Class A Common Stock's next earnings report?
Based on 5
المحللين, vTv Therapeutics Inc. Class A Common Stock is expected to report EPS of -$1.07 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان